FindTrial
Sign In

Performance evaluation test of rapid diagnostic kit for testing SARS-CoV-2/RS virus infection

Evaluation of rapid diagnostic method for SARS-CoV-2/RS virus infection - Evaluation of rapid diagnostic method for SARS-CoV-2/RS virus infection

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000048796
Enrollment
200
Registered
2022-09-01
Start date
2021-12-13
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19 infection, respiratory syncytial virus infection

Interventions

Sample collection, assay with test kit

Sponsors

Sekisui Medical Co., Ltd.
Lead Sponsor
Eiju General Hospital , Zama Childrens Clinic, Ichikawa Childrens Clinic, Abe Childrens Clinic, Kobayashi International Clinic
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients that visit the medical institution during this study, and include the following conditions: 1) Patients with symptoms suspected of COVID-19 infection or respiratory syncytial virus infection. 2) Patients who gave consent to this study.

Exclusion criteria

Exclusion criteria: 1) Patients for whom sample collection is considered difficult. 2) Patients who gave consent to this study.

Design outcomes

Primary

MeasureTime frame
Sensitivity, specificity and limits of detection for rapid diagnostic methods for SARS-CoV-2 and respiratory syncytial virus infection—

Countries

Japan

Contacts

Public ContactYuta Maehara

Sekisui Medical Co., Ltd. Research & Development

yuta.maehara@sekisui.com03-3272-0677

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026